While our retrospective analysis demonstrated that RECQL4 levels correlate with increased response to cisplatin, it should be noted that multiple studies demonstrated that high levels of RECQL4 results in resistance to cisplatin in other cancer types including breast and gastric cancer cell lines [14,15,64]. This evidence concerns the gene RECQL4 and gastric cancer.